Add as bookmark

Letters to the Editor Issue 103

by Letters(more info)

listed in letters to the editor, originally published in issue 103 - September 2004

Healing, A Labor of Love: 100 Stories of Gratitude

This book has grown out of my own amazing experiences as a healer and the conversations I’ve had with other healers around the world. As I was researching and writing my dissertation about healers, I kept hearing one amazing story after another and I couldn’t resist the opportunity to share some of these accounts with you. So far, I have collected 15 beautiful stories, written by healers, about the transformational experiences they have with clients in healing sessions. The stories focus on the healer’s gratitude for the opportunity to help another human being.

If you are a healer or know anyone practising healing arts including, but not limited to: Massage Therapy, Energy Work, Yoga Therapy, Chiropractic, Counselling, Oriental medicine, Ayurvedic medicine, Native American medicine, Western medicine, Nursing, and Midwifery, please forward this communiqué to them and consider submitting a story for the book. My goal is to collect 85 additional stories and with your help I can make that goal a reality.

Submissions need to include: name, address, email, phone number, website (if you have one), a short bio (approx. 50 words) that describes the type of practice, experience, etc., title of submission and the story. The story should be approx. 500 words. It should describe a healer-client experience that inspired or empowered you in some way. Some important themes include, but are not limited to: gratitude, love, survival, strength, courage, humility, transformation, and joy. Please do not include client names or any identifying information. Also, please include permission to edit and publish your story. Deadline is September 30, 2004.
Gabrielle Pelicci
Tel: 001 305 776 0993;;

Distant Healing Offer

I am 37 years old. I was born in Gornji Milanovac in central Serbia. It is a tradition of healing in my family; I am a forth generation of healers in my family.

My teacher was my grandmother, she taught me how to rule with my high level of energy that I was born with. There has been scientific research of bioenergy and healing I have practised for 20 years. I can heal in direct contact and in distance where I use a photograph of a patient. I can see the aura – the energetic field of the patient with my eyes; it helps me in my work.

As a curiosity, I also heal patient in my ‘dreams’ – the astral projection; in that way I healed some famous persons. To date, I have healed about 8000 people. I treat all  kind of diseases, even with treating cancer, I have good results.

In purpose of scientific research of bioenergy in 2000, I founded The Association for Development of Science with Nikola Tesla in Novi Sad,where I live now. I plan to make branches in other countries, and members from all over the world. At the moment the accent in my work is distant healing.

I send regards to your readers and  offer a free treatment for the first five readers that contact me.

Milorad Tomic

International Advocates for Health Freedom (IAHF): Breaking News: Codex, EU FSD

IAHF List: The Codex Committee on Food Labelling held a meeting recently in Montreal, Canada. The work of this committee overlaps with the work of the Codex Committee on Nutrition and Foods for Special Dietary Use.

Vitamin consumers world wide owe a debt of gratitude to the South African Codex Delegation which was represented at this meeting in Montreal by Antoinette Booyzen and Anthony Rees.

Going in to the meeting, Booyzen… and Rees had hoped to trigger an African backlash against Codex, identifying the agenda clearly as a global genocide  initiative, but after being lied to by all these countries who promised during the lunch breaks to support South Africa, when the time of reckoning came – all of these countries (along with the rest of the world including the US, Canadian, Australian, English and New Zealand governments) turned their back on the South African proposal which you can read at:

South Africa proposed a revision to the Codex General Guidelines on Claims (which currently prohibits any mention of foods serving to treat and cure diseases) based entirely on existing scientific evidence from peer reviewed scientific journals which attest to the healing properties of dietary supplements in treating a variety of diseases including:

Asthma, Arthritis, Adrenoleukodistrophy and other metabolic disorders including maple syrup urine disease, phenylketonuria, etc; hypertension, osteoperosis, migraine, osteoporosis, migraine, artherosclerosis, cholesterol reduction, constipation, bacterial infections, cardiac arrythmias, acne, allergies, Alzheimers disease, anxiety and stress, attention deficit hyperactivity disorder, Multiple Sclerosis, epilepsy, breast cancer, thyroid deficiency, Parkinson’s disease, HIV/ AIDSs, Glaucoma, influenza virus, diabetes mellitus, depression, all the classical nutrient deficiency diseases: scurvy, berri berri, rickets, kwasiorkor, etc.

South Africa proposed that CODEX bring its work into sync with current scientific findings, and that the Committee on Nutrition make changes to its preamble reflecting these current scientific findings to allow for health claims to be made for foods and nutrients.

South Africa noted that foods and nutrients are MORE EFFECTIVE than pharmaceutical drugs, which they correctly noted only address SYMPTOMS without addressing their root CAUSES.

During the coffee breaks and lunch breaks of this week long meeting whenever Booyzen and Rees met with the representatives of the 7 other African countries present at the meeting to try to secure their backing, they were PROMISED support, but last Wednesday, when they made their historic proposal, they were torpedoed even by their fellow Africans.

Prior to this meeting, the South African delegation had hoped to not only secure support from the other 7 African countries, but to then secure proxies from all the rest of Africa to bring with them to the next Codex meeting of the Committee on Nutrition and Foods For Special Dietary Uses in Bonn in November (South Africa leads the African Union), and in so doing, they had hoped to counter the effort of the European Union to ram a draconian finalized Codex vitamin standard through to completion.

They had hoped to have economists draft a white paper attesting to the economic wisdom of basing national health care systems on nutrition and prevention as vastly preferable to the existing allopathic medical model, and they’d hoped to get the rest of Africa behind these efforts.

It remains to be seen what will happen now. I hope South Africa goes ahead and PRODUCES this white paper, and I hope President Mbeki sends a letter to the United Nations CONDEMNING the Codex “process” as unscientific, undemocratic, and GENOCIDAL because that’s EXACTLY what it is.

I’ve said it before, and I’ll say it again: We can’t win at CODEX, we can ONLY win INDIRECTLY by things we do OUTSIDE of Codex which IMPACT Codex.

Right now, the ONLY thing I can see that will have even a CHANCE of stopping this global genocide agenda that threatens to destroy consumer access to dietary supplements is the Alliance for Natural Health’s (ANH) lawsuit to overturn the EU Food Supplement Directive in the European Court of Justice in Luxemborg.

ANH CAN WIN this lawsuit. The bureaucrats who crafted the EU FSD had a poor working knowledge of EU law and they put themselves on very thin ice. ANH has the best legal firm in Europe in their corner, the first firm to ever succeed at overturning an EU Directive, but the Alliance needs donations to be able to PAY this firm. Donations can be made at

Further Information
For Health Freedom,
John C Hammell, President
International Advocates for Health Freedom,
Tel: 001 800-333-2553 N.America
Tel: 001 360-945-0352 World
Source: Zeus Information Service

Cholesterol Drug Warning Issued

Three years after having recalled the cholesterol lowering statin drug Baycol, Health Canada has issued a warning concerning another statin drug, Crestor, and for the same reasons. When taken by patients with other health problems, Crestor can cause rhabdomyolosis – a wasting or breakdown of muscle tissue leading to potential kidney and heart failure (Vancouver Sun, June 19th, 2004).

It is extremely disconcerting that Health Canada – who is supposed to monitor drug safety, fails to mention that all statin drugs have the potential to cause rhabdomyolosis. It is equally troubling, that Health Canada fails to warn physicians that their patients are placed in multiple jeopardy when prescribed, along with a statin, any drug or combination of drugs such as thiazide diuretics, Beta blockers, anti diabetic drugs taken from a list of 70 other drugs that contribute to the depletion of Co Enzyme Q10 – an essential factor for cell energy function. The deficiency of this nutrient causes rhabdomyolosis. The very best diet cannot make up for such depletion. For several years Merck has a patent for their statin drug Zocor combined with Co Enzyme Q10. One must speculate why Merck has never brought the drug to market.

Is it any wonder that our sickness – pardon me – ‘health’ care system is failing for lack of money? So much of the cost can be placed at the door of adverse drug reactions, slack monitoring of dr ug safety by the federal government and the fact a majority of physicians are totally ignorant that most drugs have serious side effects because many of them induce depletion of essential nutrients, namely vitamins and minerals.

Croft Woodruff
Vancouver, BC Canada
Tel: 001 604 327 3889
Source: Chris Gupta; 21/cholesterol_drug_warning_issued.htm


Aspirin Dangerous and Ineffective for People With Heart Failure

Using aspirin for heart disease has been controversial for years, and now aspirin is in the news again. People with heart failure are often put on blood-thinning regimens with aspirin or sometimes Coumadin (warfarin), but a new study (see below) indicates that this is not helpful and could even be harmful. Results from the Warfarin/Aspirin Study in Heart Failure (WASH) show that aspirin and warfarin provide no meaningful benefit to patients with heart failure. Further, those participants who received aspirin were twice as likely as patients on warfarin to be hospitalized or to die of a cardiovascular cause and were significantly more likely to have serious gastrointestinal events.

A better and safer option than aspirin is Nattokinase, a powerful enzyme – derived from the food natto – that can dissolve blood clots and has been used safely for over 20 years. Rivalling pharmaceutical agents, Nattokinase seems to have longer lasting beneficial action without the potential for abnormal bleeding. Watch for more news about Nattokinase soon as we will offer this very potent all natural enzyme on the site this fall.

BACKGROUND: Heart failure is commonly associated with vascular disease and a high rate of athero-thrombotic events, but the risks and benefits of antithrombotic therapy are unknown.

METHODS: The current study was an open-label, randomized, controlled trial comparing no antithrombotic therapy, aspirin (300 mg/day), and warfarin (target international normalized ratio 2.5) in patients with heart failure and left ventricular systolic dysfunction requiring diuretic therapy. The primary objective was to demonstrate the feasibility and inform the design of a larger outcome study. The primary clinical outcome was death, nonfatal myocardial infarction, or nonfatal stroke.

RESULTS: Two hundred seventy-nine patients were randomized and 627 patient-years exposure were accumulated over a mean follow-up time of 27 +/- 1 months. Twenty-six (26%), 29 (32%), and 23 (26%) patients randomized to no antithrombotic treatment, aspirin, and warfarin, respectively, reached the primary outcome (ns). There were trends to a worse outcome among those randomized to aspirin for a number of secondary outcomes. Significantly (P =0.044) more patients randomized to aspirin were hospitalized for cardiovascular reasons, especially worsening heart failure.

CONCLUSIONS: The Warfarin/Aspirin Study in Heart failure (WASH) provides no evidence that aspirin is effective or safe in patients with heart failure. The benefits of warfarin for patients with heart failure in sinus rhythm have not been established. Antithrombotic therapy in patients with heart failure is not evidence based but commonly contributes to polypharmacy.

Cleland JG et al. The Warfarin/ Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.

Academic Unit, Department of Cardiology,
Castlehill Hospital, University of Hull, Kingston upon Hull, United Kingdom.
Source: Sepp (Josef) Hasslberger


  1. No Article Comments available

Post Your Comments:

About Letters


  • Liposomal Nutrients

    Optimum system for nutrient delivery to cells - fully bioavailable vitamins absorbed and metabolised

  • nutrition and cancer

    by Sandra Goodman PhD The latest scientific research regarding Nutrition and Cancer. Full details at

  • mycology research MRL

    MRL markets mushroom products food grade US & Netherlands GMP standards. Health Professional Videos

  • Super Patch Wellbeing

    Super Patches – a most revolutionary advance in wellbeing strategies in the history of medicine

  • Flower essences online

    Fine quality flower essences international ranges to help promote vitality and emotional well-being.

top of the page